Skip to content

Enhancing Working Memory, Mindfulness Level, and Quality of Life by Using Mindfulness Combined with Music Training Program in Breast Cancer Patients Undergoing Chemotherapy: An Electroencephalogram Study

Enhancing Working Memory, Mindfulness Level, and Quality of Life by Using Mindfulness Combined with Music Training Program in Breast Cancer Patients Undergoing Chemotherapy: An Electroencephalogram Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251209009
Enrollment
75
Registered
2025-12-09
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Working Memory, Mindfulness Level, and Quality of Life by Using Mindfulness Combined with Music Training Program in Breast Cancer Patients Undergoing Chemotherapy: An Electroencephalogram Study Mindfulness, Music Training, Working Memory, Breast Cancer Patients, Electroencephalography

Interventions

Participants will receive a mindfulness training program consisting of 5 sessions, with each session lasting approximately 30 minutes. In addition, they will listen to instrumental (nonlyrical) music
The Mindfulness Combined with Music Training Program.,The Mindfulness Training Program ,Receives standard care

Sponsors

Burapha University
Lead Sponsor
Chonburi Cancer Hospital
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Female patients diagnosed with breast cancer (Stage I to III), aged 20 to 60 years, who are currently receiving chemotherapy treatment. Eastern Cooperative Oncology Group (ECOG) Performance Status score between 0 to 3 No underlying medical conditions that may pose risks or interfere with participation in the study activities. No neurological disorders and screened using the Mini-Mental State Examination (MMSE). A score equal to or below the cutoff point is considered cognitive impairment. No communication or visual impairment, screened using the Jaeger chart. Scores lower than J10 indicate visual limitations and are excluded. Pain is controlled at a level below 4 on the pain rating scale. Stress level does not exceed the moderate range (less than 41 points), assessed using the Stress Test (SPST20). No depression, screened using the Two-Question Depression Screening Tool (2Q) with responses indicating (No) to both questions. Willingness to participate and provide written informed consent for the study until completion of all activities.

Exclusion criteria

Exclusion criteria: 1. Breast cancer patients who are unable to participate in all scheduled intervention sessions. 2. Patients who withdraw or refuse to continue participation during the study period. 3. Breast cancer patients who require special or intensive care from healthcare professionals during the study. 4. Patients or their primary caregivers who relocate or change hospitals during the intervention period.

Design outcomes

Primary

MeasureTime frame
Working Memory baseline, 8 weeks Operation Span (OSPAN) task,Mindfulness Level baseline, 8 weeks Philadelphia Mindfulness Scale,Quality of Life baseline, 8 weeks Functional Assessment of Cancer Therapy (Breast); FACTB score

Secondary

MeasureTime frame
Electroencephalogram baseline, 8 week Compare Amplitude of Alpha and Theta wave

Countries

Thailand

Contacts

Public ContactRangsan Chaikham

Chonburi Cancer Hospital

63810047@go.buu.ac.th0817730740

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026